-+ 0.00%
-+ 0.00%
-+ 0.00%

IMMUNEERING TO COLLABORATE WITH ASTELLAS ON CLINICAL STUDIES OF INVESTIGATIONAL CLDN18.2 PROGRAMS IN COMBINATION WITH ATEBIMETINIB FOR PANCREATIC CANCER PATIENTS

Reuters·11/12/2026 12:30:00

Please log in to view news